Valuing outcomes in health care: A comparison of willingness to pay and quality-adjusted life-years

Journal of Clinical Epidemiology

Volumn 51, Issue 8, 1998, Pages 667-676

  Bala, Mohan V ^a   Wood, Lisa L ^a   Zarkin, Gary A ^a   Norton, Edward C ^b   Gafni, Amiram ^c   O'Brien, Bernie ^c  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Health outcomes; QALYs; Valuation; WTP

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; CORRELATION FUNCTION; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HERPES ZOSTER; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

AGED; ATTITUDE TO HEALTH; COMPUTERS; COST OF ILLNESS; DRUG COSTS; FEMALE; FLORIDA; HERPES ZOSTER; HUMANS; LINEAR MODELS; MALE; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME;

EID: 0032143054     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00036-5     Document Type: Article

References (40)

1. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences - IV. Progress and a research agenda J Clin Epidemiol. 42(7):1989;675-685.
2. Torrance G.W. Measurement of health state utilities for economic appraisal. A review. J Health Econ. 5(4):1986;1-30.
3. Hornberger J.C., Redelmeier D.A., Petersen J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol. 45(5):1992;505-512.
4. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences - I. Measurement strategies J Clin Epidemiol. 42(7):1989;345-354.
5. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences - II. Scaling methods J Clin Epidemiol. 42(7):1989;459-471.
6. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences - III. Population and context effects J Clin Epidemiol. 42(7):1989;585-592.
7. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-Effectiveness in Health and Medicine. 1994;Oxford University Press, New York, NY.
8. Tolley G., Kenkel D., Fabian R. Valuing Health for Policy. An Economic Approach:1994;University of Chicago Press, Chicago, IL.
9. Mehrez A., Gafni A. Preference-based outcome measures for economic evaluation of drug interventions. Quality adjusted life years (QALYs) versus healthy years equivalents (HYEs) PharmacoEconomics. 1(5):1992;338-345.
10. Read J.L., Quinn R.J., Berwick D.M., Fineberg H.V., Weinstein M.C. Preferences for health outcomes. Comparison of assessment methods Med Decision Mak. 4(3):1984;315-329.
11. Gerard K. Cost-utility in practice. A policy maker's guide to the state of the art Health Policy. 21:1992;249-279.
12. Nord E. Toward quality assurance in QALY calculations. Int J Tech Assess Health Care. 9(1):1993;37-45.
13. Pliskin J.S., Shepard D.S., Weinstein M.C. Utility functions for life-years and health status. Operations Research. 28:1980;206-224.
14. Weinstein M.C., Fineberg H.C., Elstein A.S., Fragier H.S., Neuhauser D.et al. Clinical Decision Analysis. 1980;W.B. Saunders, Philadelphia, PA.
15. von Neumann J., Morgenstern O. Theory of Games and Behavior. 1953;John Wiley, New York, NY.
16. Miyamoto J.M., Eraker S.A. Parameter estimates for a QALY utility model. Med Decis Making. 5:1985;191-213.
17. Torrance G.W., Feeny D. Utilities and quality-adjusted life-years. Int J Tech Assess Health Care. 28:1989;559-578.
18. Gafni A., Birch S. Preferences for outcomes in economic evaluation. An economic approach to addressing economic problems Soc Sci Med. 40:1995;767-776.
19. Mitchell R.C., Carson R.T. Using Surveys to Value Public Goods. The Contingent Valuation Method:1989;Resources for the Future, Inc, Washington, DC.
20. Johannesson M., Jönsson B. Economic evaluation in health care. Is there a role for cost-benefit analysis? Health Policy. 17:1991;1-23.
21. Pauly M.V. Valuing health care benefits in money terms. Sloan F.A. Valuing Health Care. 1995;Cambridge University Press, Cambridge, UK.
22. Thompson M.S. Willingness to pay and accept risks to cure chronic disease. Am J Public Health. 76(4):1986;392-396.
23. Appel L.J., Steinberg E.P., Powe N.R., Anderson G.F., Dwyer S.A., Faden R.R. Risk reduction from low osmolality contrast media. Med Care. 28(4):1990;324-334.
24. Eastaugh S.R. Valuation of the benefits of risk-free blood. Int J Tech Assess Health Care. 7(1):1991;51-57.
25. Johannesson M. Economic evaluation of lipid lowering. A feasibility test of the contingent valuation approach Health Policy. 20:1992;309-320.
26. Neumann P.J., Johannesson M. The willingness to pay for in vitro fertilization. A pilot study using contingent valuation Med Care. 32(7):1994;686-699.
27. O'Brien B., Viramontes J.L. Willingness to pay. A valid and reliable measure of health state preference? Med Decis Making. 14(3):1994;289-297.
28. McKendrick M.W., McGill J.I., White J.E., Wood M.J. Oral acyclovir in acute herpes zoster. Br Med J. 293:1986;1529-1532.
29. Hanemann M., Loomis J., Kanninen B. Statistical efficiency of double-bounded dichotomous choice contingent valuation. Am Ag Econ Assoc. 73(4):1991;1255-1263.
30. Gafni A. Using willingness-to-pay as a measure of benefits. What is the relevant question to ask in the context of public decision making about health care programs Med Care. 29:1991;1246-1252.
31. O'Brien B., Gafni A. When do the dollars make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making. 16:1996;288-299.
32. Knetsch JL, Kahneman D. Assessing non-pecuniary environmental value: A further report on anchoring, additivity, question format bias, and fairness tests. (working paper) Burnaby, BC, Canada: Department of Economics, Simon Fraser University; 1984.
33. Boyle K.J., Bishop R.C., Welsh M.P. Starting point bias in contingent valuation bidding games. Land Economics. 61(May):1985;188-195.
34. Hanemann W.M. Welfare evaluations in contingent valuation experiments with discrete responses. Am J Ag Econ. 66(3):1984;332-341.
35. Cameron T.A., James M.D. Efficient estimation methods for "closed-ended" contingent valuation surveys. Review Econ Stat. 69:1987;269-276.
36. Cameron T.A. A new paradigm for valuing non-market goods using referendum data. Maximum likelihood estimation by censored logistic regression J Environ Econ Manage. 15:1988;355-379.
37. Gafni A. The standard gamble method. What is being measured and how is it interpreted? Health Serv Res. 29(2):1994;207-224.
38. Mehrez A., Gafni A. Quality-adjusted life-years, utility theory, and healthy-years equivalents. Med Decis Making. 9(2):1989;142-149.
39. Broome J. Qalys. J Public Econo. 50(2):1993;149-167.
40. Johannesson M., Pliskin J.S., Weinstein M.C. A note on qalys, time trade-off, and discounting. Med Decis Making. 18:1994;188-193.